Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake.
A patient developed an adult-onset dermatomyositis-like syndrome characterized by skin rash and progressive proximal muscle weakness concurrent with the intake of simvastatin. Despite discontinuation of the statin, symptoms progressed and required conventional steroid therapy for remission. The association between statins and the development of a musculocutaneous syndrome closely resembling dermatomyositis in susceptible subjects is poorly understood and has been reported rarely. The purpose of this report is to provide additional support for this pathological association. Since the population receiving statins is large and rapidly growing, caregivers are urged to be alert regarding the early recognition and proper care of the spectrum of neuromuscular complications linked to statin intake.
Vasconcelos
Olavo M
OM
Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Campbell
William W
WW
D000368:Aged; D003882:Dermatomyositis / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008297:Male; D013577:Syndrome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors